Davis's Drug Guide
vilobelimab
General
Pronunciation:
vil-oh-bel-i-mab
Trade Name(s)
- Gohibic
Ther. Class.
Pharm. Class.
complement inhibitors
monoclonal antibodies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Vilobelimab." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580109/all/vilobelimab.
Vallerand AHA, Sanoski CAC, . Vilobelimab. Davis's Drug Guide. F.A. Davis Company; 2025. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580109/all/vilobelimab. Accessed April 21, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Vilobelimab. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580109/all/vilobelimab
Vallerand AHA, Sanoski CAC, . Vilobelimab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 April 21]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580109/all/vilobelimab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - vilobelimab
ID - 3580109
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580109/all/vilobelimab
PB - F.A. Davis Company
ET - 19
DB - Anesthesia Central
DP - Unbound Medicine
ER -
